Literature DB >> 12743565

Experimental rhinovirus challenges in adults with mild asthma: response to infection in relation to IgE.

Juan C Zambrano1, Holliday T Carper, Gary P Rakes, James Patrie, Deborah D Murphy, Thomas A E Platts-Mills, Frederick G Hayden, Jack M Gwaltney, Tina K Hatley, Angela M Owens, Peter W Heymann.   

Abstract

BACKGROUND: Although most children and young adults with asthma are atopic, exacerbations of asthma are frequently associated with viral respiratory tract infections, especially those caused by rhinovirus (HRV).
OBJECTIVE: Young atopic adults with mild asthma were evaluated before and during an experimental HRV infection to test the hypothesis that airway inflammation before virus inoculation may be a risk factor for an adverse response to HRV.
METHODS: Experimental HRV infections were evaluated in 16 allergic volunteers with mild asthma and 9 nonatopic control patients (age, 18 to 30 years). Before virus inoculation, each participant was screened with tests for lung function, prick skin tests for sensitization to common aeroallergens, measurements of total serum IgE, and serum neutralizing antibody to rhinovirus-16 (the serotype used for inoculation). The response to infection was monitored for 21 days by using symptom diary cards, tests for lung function, and markers of airway inflammation in nasal washes, blood, and expired air.
RESULTS: During the infection, asthmatic patients had cumulative upper and lower respiratory tract symptom scores that were significantly greater over the course of 21 days than scores from the control patients. At baseline, the asthmatic patients also had increased sensitivity to methacholine and significantly lower values for FEV(1) (percent predicted) than the control patients (geometric mean and intraquartile values: 87% [79% to 91%] for the asthmatic patients and 101% [90% to 104%] for the control patients, P <.03). Among the patients with mild asthma, 6 had levels of total serum IgE that were substantially elevated (range, 371 to 820 IU/mL) compared with 10 who had lower levels (range, 29 to 124 IU/mL). Those with high levels of IgE had significantly greater lower respiratory tract symptom scores during the initial 4 days of the infection than the low IgE group. They also had higher total blood eosinophil counts at baseline, increased eosinophil cationic protein in their nasal washes (>200 ng/mL), and augmented levels of expired nitric oxide at baseline and during peak cold symptoms. In contrast, levels of soluble intracellular adhesion molecule-1 in nasal wash supernatants from the asthmatic patients with high IgE were diminished, both at baseline and during the infection.
CONCLUSIONS: The reduced lung function and increased markers of inflammation observed before virus inoculation in the asthmatic patients who had high levels of total serum IgE may be risk factors for an adverse response to infections with HRV.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12743565     DOI: 10.1067/mai.2003.1396

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  61 in total

1.  Exacerbation-Prone Asthma.

Authors:  Loren C Denlinger; Peter Heymann; Rene Lutter; James E Gern
Journal:  J Allergy Clin Immunol Pract       Date:  2019-11-22

2.  Human TH1 and TH2 cells targeting rhinovirus and allergen coordinately promote allergic asthma.

Authors:  Lyndsey M Muehling; Peter W Heymann; Paul W Wright; Jacob D Eccles; Rachana Agrawal; Holliday T Carper; Deborah D Murphy; Lisa J Workman; Carolyn R Word; Sarah J Ratcliffe; Brian J Capaldo; Thomas A E Platts-Mills; Ronald B Turner; William W Kwok; Judith A Woodfolk
Journal:  J Allergy Clin Immunol       Date:  2020-04-19       Impact factor: 10.793

3.  IgE expression pattern in lung: relation to systemic IgE and asthma phenotypes.

Authors:  Silvana Balzar; Matthew Strand; Diane Rhodes; Sally E Wenzel
Journal:  J Allergy Clin Immunol       Date:  2007-02-23       Impact factor: 10.793

Review 4.  The role of chemokines in virus-associated asthma exacerbations.

Authors:  Lara E Kallal; Nicholas W Lukacs
Journal:  Curr Allergy Asthma Rep       Date:  2008-09       Impact factor: 4.806

5.  Deciphering the importance of host and environmental factors that influence the genesis of asthma during childhood.

Authors:  Peter W Heymann; Thomas A E Platts-Mills
Journal:  J Infect Dis       Date:  2012-09-25       Impact factor: 5.226

6.  Rhinovirus C15 Induces Airway Hyperresponsiveness via Calcium Mobilization in Airway Smooth Muscle.

Authors:  Vishal Parikh; Jacqueline Scala; Riva Patel; Corinne Corbi; Dennis Lo; Yury A Bochkov; Joshua L Kennedy; Richard C Kurten; Stephen B Liggett; James E Gern; Cynthia J Koziol-White
Journal:  Am J Respir Cell Mol Biol       Date:  2020-03       Impact factor: 6.914

Review 7.  IgE in the diagnosis and treatment of allergic disease.

Authors:  Thomas A E Platts-Mills; Alexander J Schuyler; Elizabeth A Erwin; Scott P Commins; Judith A Woodfolk
Journal:  J Allergy Clin Immunol       Date:  2016-04-27       Impact factor: 10.793

8.  Rhinovirus-associated wheeze during infancy and asthma development.

Authors:  Tuomas Jartti; James E Gern
Journal:  Curr Respir Med Rev       Date:  2011-06-01

9.  Predicting worsening asthma control following the common cold.

Authors:  M J Walter; M Castro; S J Kunselman; V M Chinchilli; M Reno; T P Ramkumar; P C Avila; H A Boushey; B T Ameredes; E R Bleecker; W J Calhoun; R M Cherniack; T J Craig; L C Denlinger; E Israel; J V Fahy; N N Jarjour; M Kraft; S C Lazarus; R F Lemanske; R J Martin; S P Peters; J W Ramsdell; C A Sorkness; E R Sutherland; S J Szefler; S I Wasserman; M E Wechsler
Journal:  Eur Respir J       Date:  2008-09-03       Impact factor: 16.671

10.  A rat model of picornavirus-induced airway infection and inflammation.

Authors:  Louis A Rosenthal; Svetlana P Amineva; Renee J Szakaly; Robert F Lemanske; James E Gern; Ronald L Sorkness
Journal:  Virol J       Date:  2009-08-11       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.